Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02

August 11, 2016 4:18 PM EDT
Get Alerts HRT Hot Sheet
Trade HRT Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Arrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of $0.02, versus $0.04 reported last year. Revenue for the quarter came in at $5.13 million, versus $5.66 million reported last year.

For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment